Showing results (521-530 of 577) with videos related to

Sort By:
Pageof 58
JAMA Neurology|July 11, 2017
Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of ChoreaSamuel Frank, David Stamler, Elise Kayson, et al.
Developmental Medicine and Child Neurology|February 3, 2009
Coprophenomena in Tourette syndromeRoger D Freeman, Samuel H Zinner, Kirsten R Müller-Vahl, et al.
Neurogenetics|April 7, 2010
LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson diseaseCarles Vilariño-Güell, Christian Wider, Owen A Ross, et al.
Annals of Neurology|January 26, 2012
Head injury, α-synuclein Rep1, and Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2014
Peptidoglycan recognition protein genes and risk of Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Neurology. Genetics|May 14, 2021
Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor SubtypesIsabel Alfradique-Dunham, Rami Al-Ouran, Rainer von Coelln, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2020
Clinical and Demographic Characteristics of Upper Limb DystoniaScott A Norris, Hyder A Jinnah, Christine Klein, et al.
Neurology. Genetics|April 29, 2016
Clinical and genetic features of cervical dystonia in a large multicenter cohortMark S LeDoux, Satya R Vemula, Jianfeng Xiao, et al.
Frontiers in Neurology|October 4, 2021
Oromandibular Dystonia: A Clinical Examination of 2,020 CasesLaura M Scorr, Stewart A Factor, Sahyli Perez Parra, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2006
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planChristopher G Goetz, Stanley Fahn, Pablo Martinez-Martin, et al.
Pageof 58